U.S. Urology Devices Market Size, Share & COVID-19 Impact Analysis, By Product Type (Endoscopes, Laser & Lithotripsy Devices, Dialysis Devices, Accessories, and Other Devices), By Application (Urolithiasis, Urethral Malignancies, Bladder Disorders, Kidney Diseases, and Others), By End-user (Hospitals & Ambulatory Surgical Centers, Dialysis Centers, and Others), and Country Forecast, 2023-2030

The U.S. urology devices market size was worth USD 11.52 billion in 2022 and is projected to grow at a CAGR of 6.2% during the forecast period. 

Urology devices are used to diagnose and treat various urological disorders such as kidney diseases, bladder disorders, urolithiasis, and urethral malignancies. The increasing incidence of urological disorders, rising geriatric population, and technological advancements are the few factors driving the U.S. urology devices market growth.

• For instance, according to the data published by the Centers for Disease Control and Prevention in 2023, more than 1 in 7 U.S adults, i.e., around 35.5 million people, or 14%, are projected to have chronic kidney diseases. Such instances are projected to lead to the adoption of treatment options, thereby influencing the U.S. market size.

In 2020, the impact of COVID-19 on the market was negative, owing to the decline in the demand for urology devices. The decline was mainly attributed to the delays in elective surgeries and lower patient volumes.

LATEST TRENDS

Growing Preference for Minimally Invasive Urological Procedures 

Minimally invasive surgical procedures have undergone a revolutionary transformation driven by a growing emphasis on patient-centered care and technologically advanced treatments. The adoption of novel technologies, such as lasers and robotic systems for the treatment of benign and malignant urologic conditions, has led to the emergence of new minimally invasive surgical techniques (MISTs).

Minimally invasive robotic and laparoscopy surgeries have become the cornerstone of pelvic cancer surgery, providing an alternative to traditional open surgery. The high-intensity focused ultrasound (HIFU) and robotic brachytherapy, prostatectomy, cryotherapy, and radiotherapy are now commonly used for the treatment of prostate cancer. Moreover, MISTs have given a new approach to the surgical treatment of benign prostate hyperplasia (BPH).

• For instance, laser treatments, including GreenLight, Holmium, and Thulium, as well as water-based treatments such as Aquablation and Rezum, and other minimally invasive procedures such as prostate artery embolization (PAE), Urolift, TIND have been increasingly used.

DRIVING FACTORS

Increasing Prevalence of Urological Disorders to Propel Market Growth

The primary factor behind the increased adoption of urology devices in the country is the rising incidence of urological disorders such as Urinary Tract Infections (UTIs). For instance, according to the data published by the Urology Care Foundation, urinary tract infections are the second most common infection in the U.S. and are the reason for more than 8 million visits to the doctor every year. However, increased awareness regarding the treatment options, increasing healthcare expenditure, and new product launches have increased the demand for urology devices.

Chronic kidney diseases are more common in people aged 65 or above than in those aged between 45–64 and 18–44.

RESTRAINING FACTORS

Adverse Effects Related to Urological Devices May Hamper Market Growth 

Several complications, such as bleeding, infections, and contaminations associated with urological endoscopes, have reduced the adoption of urology devices in the market.  For instance, in April 2021, the U.S. FDA unveiled that it had received various medical device reports describing issues related to patient infections and other possible contamination issues associated with urological endoscopes, including cystoscopes, ureteroscopes, and cystourethroscopes. Such instances, along with the high cost of urology devices, might hamper the growth of the market to a certain extent.

SEGMENTATION

By Product Type Analysis

Based on product type, the market is classified into endoscopes, laser & lithotripsy devices, dialysis devices, accessories, and other devices.

In 2022, the accessories segment accounted for the largest U.S. urology devices market share owing to the growing focus of major players on developing advanced urological accessories in the market. Furthermore, rising patient visits to urology clinics and the growing adoption of catheters and dilators in urology clinics for treatment are projected to drive segment growth during the forecast period.

The endoscopes segment is anticipated to grow significantly in the coming years, owing to the high demand for disposable cystoscopes in the U.S., the growing prevalence of urolithiasis among the population, and new product launches by market players.

• For instance, in January 2023, PENTAX Medical launched PENTAX Medical INSPIRA, the new premium video processor, and the i20c video endoscope series. It helps physicians enhance clinical outcomes.

By Application Analysis

By application, the U.S. market is divided into urethral malignancies, urolithiasis, kidney diseases, bladder disorders, and others.

The kidney diseases segment accounted for the highest market share in 2022 owing to the increasing prevalence of diseases such as diabetes and hypertension, indicating a higher chance of people suffering from kidney disease. Furthermore, the growing demand for dialysis procedures in the country and new product launches in the market are projected to drive segment growth over the forecast period.

• For instance, according to the United States Renal Data System, in 2020, approximately 786,000 people in the U.S. were suffering from end-stage kidney disease, and the number is projected to grow over the forecast period.

The urethral malignancies segment is expected to grow at the highest CAGR during the forecast period of 2023-2030. The segment growth can be attributed to the rise in the prevalence of urinary tract cancer cases and the increase in the senior population, who are more prone to urinary tract infections. Moreover, growth in the funding from private & government organizations for the development of research centers and advancement in R&D activities in the healthcare division are other factors influencing the segment growth.

By End-user Analysis

In terms of end-user, the U.S. market is categorized into dialysis centers, hospitals & ambulatory surgical centers, and others.

In 2022, the hospitals & ambulatory surgical centers segment accounted for the highest market share due to increasing patient visits with urology-related disorders to hospitals & ASCs.

• For instance, according to data published by the U.S. Organ Procurement and Transplantation Network in 2021, around 22,817 kidney transplants were performed in the U.S. in 2020.

The dialysis centers segment is anticipated to grow substantially over the forecast period. The rising number of chronic kidney disease patients in dialysis centers and the rising emphasis of prominent market players to target dialysis centers contribute to the segment growth.

KEY INDUSTRY PLAYERS

Boston Scientific Corporation, Fresenius Medical Care AG & Co., Coloplast A/S, and Ethicon, Inc. are competitive players in the U.S. market. The strong presence of these companies is mainly attributed to the growing product approvals and research and development activities to bring innovative solutions to the urology market. For instance, in February 2023, Boston Scientific Corporation received FDA Clearance for the LithoVue Elite single-use digital flexible ureteroscope system. Moreover, Olympus Corporation, Siemens Healthcare GmbH, Stryker, Cook Medical, and KARL STORZ SE & Co. KG (Germany) are a few other companies operating in the market.

LIST OF KEY COMPANIES PROFILED:

• Boston Scientific Corporation (U.S.)


• Coloplast A/S (Denmark)


• Ethicon, Inc. (Johnson & Johnson Services, Inc.) (U.S.)


• Ambu A/S (Denmark)


• Olympus Corporation (Japan)


• Siemens Healthcare GmbH (Germany)


• Stryker (U.S.)


• Cook Medical (U.S.)


• KARL STORZ SE & Co. KG (Germany)


• Fresenius Medical Care AG & Co (Germany)

KEY INDUSTRY DEVELOPMENTS: 

• March 2022 – Strive Medical, a U.S. based provider of urology supplies, announced the acquisition of the urology division of U.S. Medical Supply, a subsidiary of Advanced Diabetes Supply (“ADS”), to strengthen its market presence.


• February 2022 – Blue Light system product of KARL STORZ SE & Co. K.G. received U.S. FDA approval to detect non-muscle-invasive bladder cancer (NMIBC).


• September 2020 – Ambu A/S announced that it has partnered with UroGPO, the most significant purchasing organization for urology practice clinics in the U.S. This partnership allowed Ambu A/S to access private urology clinic centers across the U.S.

REPORT COVERAGE

The report provides a detailed analysis of the U.S. market. It focuses on key aspects such as the prevalence of urinary disorders and new product launches.  In addition, it includes critical industry developments such as partnerships, mergers & acquisitions and the impact of COVID-19 on the market. Besides this, the research report also offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market over recent years.

Report Scope & Segmentation